Carl Power, PhD; John E.J. Rasko, MBBS, PhD
In the past few years, relatively straightforward laboratory techniques have been developed to reprogram normal body cells to enter an embryonic stem cell–like state. Not only do these induced pluripotent stem cells hold great medical promise—perhaps greater than that of embryonic stem cells—but they also have escaped the ethical controversy in which the latter is mired.
This article examines how cell reprogramming is likely to transform regenerative and reproductive medicine and highlights some of the medical, moral, and political hurdles that it faces. It also argues that induced pluripotent stem cells are more ethically problematic than most people believe and that cell reprogramming will not solve the stem cell controversy but complicate it further.
Power C, Rasko JE. Will Cell Reprogramming Resolve the Embryonic Stem Cell Controversy? A Narrative Review. Ann Intern Med. ;155:114–121. doi: 10.7326/0003-4819-155-2-201107190-00007
Download citation file:
Published: Ann Intern Med. 2011;155(2):114-121.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use